「Design of a chimeric ACE-2/Fc-silent fusion protein with ultrahigh affinity and neutralizing capacity for SARS-CoV-2 variants」の関連論文
-
Isolation of a human SARS-CoV-2 neutralizing antibody from a synthetic phage library and its conversion to fluorescent biosensors
-
Studies on genetic polymorphisms of host cell receptors affecting viral entry into cells
-
Dual inhibition of TMPRSS2 and Cathepsin B prevents SARS-CoV-2 infection in iPS cells
-
Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants
-
SARS-CoV-2 Omicron BA.2.75 Variant May Be Much More Infective than Preexisting Variants Based on In Silico Model
-
An attenuated vaccinia vaccine encoding the severe acute respiratory syndrome coronavirus-2 spike protein elicits broad and durable immune responses, and protects cynomolgus macaques and human angiotensin-converting enzyme 2 transgenic mice from severe acute respiratory syndrome coronavirus-2 and its variants
-
Studies on zoonotic viruses isolated from wild animals with an optimal isolation method for protease-dependent viruses
-
Virological characteristics of the SARS-CoV-2 Omicron BA.2.75 variant
-
Fourth mRNA vaccination increases cross-neutralizing antibody titers against SARS-CoV-2 variants, including BQ.1.1 and XBB, in a very elderly population
-
Insights from a computational analysis of the SARS-CoV-2 Omicron variant: Host-pathogen interaction, pathogenicity, and possible drug therapeutics
-
Identification and Analysis of Monoclonal Antibodies with Neutralizing Activity against Diverse SARS-CoV-2 Variants
-
All-Trans Retinoic Acid Exhibits Antiviral Effect against SARS-CoV-2 by Inhibiting 3CLpro Activity
-
Construction and evaluation of a self-replicative RNA vaccine against SARS-CoV-2 using yellow fever virus replicon
-
iPSC screening for drug repurposing identifies anti‐RNA virus agents modulating host cell susceptibility
-
Antiviral effect of cetylpyridinium chloride in mouthwash on SARS-CoV-2
-
Neutralizing antibody-dependent and -independent immune responses against SARS-CoV-2 in cynomolgus macaques.
-
Convergent evolution of SARS-CoV-2 Omicron subvariants leading to the emergence of BQ.1.1 variant
-
Studies on potential role of nonneutralizing IgA antibodies in cross-protective immunity against influenza A viruses
-
Study on serological diagnostic assays for Crimean-Congo hemorrhagic fever
-
Automated amplification-free digital RNA detection platform for rapid and sensitive SARS-CoV-2 diagnosis
-
Production and characterization of monoclonal antibodies specific for major capsid VP1 protein of trichodysplasia spinulosa-associated polyomavirus
-
Study on chemical compounds for the development of anti-ebolavirus drugs [an abstract of entire text]
-
Glycan Cluster Shielding and Antibody Epitopes on Lassa Virus Envelop Protein
-
Study on Immunological Detection of Swine Influenza Virus Using Rabbit Monoclonal Antibody
-
Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5
-
Construction of Fosmid-based SARS-CoV-2 replicons for antiviral drug screening and replication analyses in biosafety level 2 facilities
-
Engineering a human IgG2 antibody stable at low pH
-
Site-directed mutagenesis study of host and viral proteins : single nucleotide variants of human TBK1 and functional sites of ebolavirus VP35
-
Population genetics of variants in infectious diseases and its application to the prediction of variant replacement
-
SARS-CoV-2 spike receptor-binding domain is internalized and promotes protein ISGylation in human induced pluripotent stem cell-derived cardiomyocytes
-
Generation of molecular-targeting peptides for selective inhibition of the interaction between CTLA-4 and B7 in the dog: a new immune checkpoint inhibitor for cancer therapy
-
Research for elucidation of immune evasion mechanisms and development of a novel immunotherapy for cancer in dogs [an abstract of entire text]
-
Exocyst complex component 2 is a potential host factor for SARS-CoV-2 infection
-
Promising SARS-CoV-2 main protease inhibitor ligand-binding modes evaluated using LB-PaCS-MD/FMO
-
De novo Selection of Macrocyclic Peptides Binding to TMEPAI family by Means of Random Non-standard Peptides Integrated Discovery System
-
Evaluation and selection of potent fluorescent immunosensors by combining fluorescent peptide and nanobodies displayed on yeast surface
-
Panning-based Virus Receptor Screening with Cellular cDNA Library
-
Collective fusion activity determines neurotropism of an en bloc transmitted enveloped virus
-
Self-assembling small-molecule adjuvants as antigen nano-carriers
-
Identification of Virus Receptors
-
Modeling SARS-CoV-2 infection and its individual differences with ACE2-expressing human iPS cells
-
Discovery of Non-Cysteine-Targeting Covalent Inhibitors by Activity-Based Proteomic Screening with a Cysteine-Reactive Probe
-
Studies on development of novel therapeutic agent against RNA virus infection
-
Studies on cell tropism of hemorrhagic fever viruses and mechanisms of entry into cells
-
Study on the control of high pathogenicity and low pathogenicity avian influenza in Vietnam [an abstract of entire text]
-
Japanese Encephalitis DNA Vaccines with Epitope Modification Reduce the Induction of Cross-Reactive Antibodies against Dengue Virus and Antibody-Dependent Enhancement of Dengue Virus Infection
-
Characterization of ferret Pit1 as a receptor of feline leukemia virus subgroup B
-
Whole-genome sequence and genesis of an avian influenza virus H5N1 isolated from a healthy chicken in a live bird market in Indonesia: accumulation of mammalian adaptation markers in avian hosts
-
ベンジルイソキノリンアルカロイド、ヒゲナミンおよびベルベリン検出のためのバイオアッセイの開発
-
Effects of Traditional Kampo Drugs and Their Constituent Crude Drugs on Influenza Virus Replication In Vitro: Suppression of Viral Protein Synthesis by Glycyrrhizae Radix